Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In Vitro and in Vivo Uncaging and Bioluminescence Imaging by Using Photocaged Upconversion Nanoparticles

Innenrücktitelbild: In Vitro and In Vivo Uncaging and Bioluminescence Imaging by Using Photocaged Upconversion Nanoparticles (Angew. Chem. 13/2012)

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers

In vivo ultrasound-induced luminescence molecular imaging

High-Contrast Visualization of Upconversion Luminescence in Mice Using Time-Gating Approach

Temporal Multiplexed in Vivo Upconversion Imaging.

High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors.

In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers

Hybrid Nanoclusters for Near-Infrared to Near-Infrared Upconverted Persistent Luminescence Bioimaging.

Upconversion Luminescence Imaging Techniques and Their Application in Targeted Bioimaging

Dye-Sensitized Core/Active Shell Upconversion Nanoparticles for Optogenetics and Bioimaging Applications

Camouflage Nanoparticles Enable in Situ Bioluminescence-Driven Optogenetic Therapy of Retinoblastoma

Upconversion Nanoparticles: A Versatile Solution to Multiscale Biological Imaging

Ultrabright and ultrafast afterglow imaging in vivo via nanoparticles made of trianthracene derivatives

Upconversion Nanophosphors for Bioimaging

Near-Infrared Frequency Upconversion Luminescence Bioimaging Based on Cyanine Nanomicelles

DNA Nanomachine Activation and Zn2+ Imaging in Living Cells with Single NIR Irradiation.

Recent Advances of Upconversion Nanomaterials in the Biological Field

Bioimaging with Upconversion Nanoparticles

Blue-emissive Upconversion Nanoparticles for Low-Power-excited Bioimaging in Vivo.